ArgusEye closes €2.8 million funding to accelerate bioprocessing

FHS
May 13, 2024
11:04 am

ArgusEye, a provider of innovative sensor solutions for real-time monitoring of biological systems, today announced the close of its funding, raising €2.8 million EUR (~£2.4 million GBP) bringing the total raised by the Company to €3.45 million EUR (~£3 million GPB).

Oregon jury says J&J owes talc claimant $260M

An Oregon jury awarded a talc claimant $260 million in a verdict against Johnson & Johnson on Monday. The case was brought by a 49

June 6, 2024

New subset of T cells may enhance cancer immunotherapy

A team of cancer researchers, led by the University of Houston, has discovered a new subset of T cells that may improve the outcome for

May 28, 2024

Frontier Bio’s Lab-Grown Lungs Offers Hope for Drug Development

What You Should Know: – Frontier Bio Corporation has successfully created complex microscale lung tissue by combining 3D bioprinting with the self-assembling capabilities of stem

October 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.